GRI BIO, Inc.
Related Filers (23)
- Kelly Leanne (5)
- Thorell Marella (5)
- Baker David Charles (5)
- SALMON Pharma GmbH (4)
- Payne Joseph E (4)
- Ammer Richard (4)
- Chaturvedi Vipin (3)
- Hertz Walter Marc (3)
- Agro Albert (3)
- Arcturus Therapeutics Holdings Inc. (2)
- Levi Ofir (2)
- Toren Penny (2)
- Chhabra Meenu (2)
- Markey John (2)
- BIGGER CAPITAL FUND L P (2)
- Lind Global Fund II LP (2)
- Altium Capital Management LP (2)
- Szekeres David Leslie (2)
- Rongen Roelof (2)
- SIMPSON CAMILLA V (2)
- Malnik Dov (1)
- Lincoln Park Capital Fund, LLC (1)
- TEP Biotech, LLC (1)
- Show More ...
Financials (12)
10-Q
Tuesday, 11/14/2023
Quarterly Report for period ending 2023-09-30
10-Q
Monday, 8/14/2023
Quarterly Report for period ending 2023-06-30
10-Q
Monday, 5/15/2023
Quarterly Report for period ending 2023-03-31
10-K
Friday, 2/24/2023
Annual Report for period ending 2022-12-31
10-Q
Thursday, 11/3/2022
Quarterly Report for period ending 2022-09-30
10-Q
Thursday, 7/28/2022
Quarterly Report for period ending 2022-06-30
10-Q
Monday, 5/9/2022
Quarterly Report for period ending 2022-03-31
10-K
Monday, 2/14/2022
Annual Report for period ending 2021-12-31
10-Q
Friday, 11/12/2021
Quarterly Report for period ending 2021-09-30
10-Q
Tuesday, 8/10/2021
Quarterly Report for period ending 2021-06-30
10-Q
Thursday, 5/13/2021
Quarterly Report for period ending 2021-03-31
10-K
Monday, 3/29/2021
Annual Report for period ending 2020-12-31
News (53)
8-K
Friday, 2/2/2024
Current report filing
8-K
Tuesday, 1/30/2024
Current report filing
8-K
Friday, 1/19/2024
Current report filing
8-K
Tuesday, 1/16/2024
Current report filing
8-K
Monday, 1/8/2024
Current report filing
8-K
Tuesday, 12/5/2023
Current report filing
8-K
Monday, 11/27/2023
Current report filing
8-K
Friday, 11/24/2023
Current report filing
8-K
Wednesday, 11/15/2023
Current report filing
8-K
Wednesday, 11/1/2023
Current report filing
8-K
Friday, 8/25/2023
Current report filing
8-K
Wednesday, 8/23/2023
Current report filing
8-K
Monday, 8/14/2023
Current report filing
8-K
Friday, 7/7/2023
Current report filing
8-K/A
Thursday, 7/6/2023
Current report filing
8-K/A
Friday, 5/26/2023
Current report filing
8-K
Thursday, 4/27/2023
Current report filing
8-K
Thursday, 4/27/2023
Current report filing
8-K
Friday, 4/21/2023
Current report filing
8-K
Friday, 4/21/2023
Current report filing
8-K
Wednesday, 4/12/2023
Current report filing
8-K
Friday, 4/7/2023
Current report filing
8-K
Tuesday, 4/4/2023
Current report filing
8-K
Friday, 3/31/2023
Current report filing
8-K
Thursday, 3/2/2023
Current report filing
8-K
Friday, 2/24/2023
Current report filing
8-K
Wednesday, 1/11/2023
Current report filing
8-K
Thursday, 12/29/2022
Current report filing
8-K
Tuesday, 12/13/2022
Current report filing
8-K
Thursday, 11/3/2022
Current report filing
8-K
Thursday, 7/28/2022
Current report filing
8-K
Tuesday, 7/26/2022
Current report filing
8-K
Wednesday, 7/13/2022
Current report filing
8-K
Tuesday, 6/28/2022
Current report filing
8-K
Friday, 6/10/2022
Current report filing
8-K
Wednesday, 5/18/2022
Current report filing
8-K
Friday, 5/13/2022
Current report filing
8-K
Thursday, 5/12/2022
Current report filing
8-K
Monday, 5/9/2022
Current report filing
8-K
Friday, 4/22/2022
Current report filing
8-K
Wednesday, 3/30/2022
Current report filing
8-K
Monday, 3/21/2022
Current report filing
8-K
Monday, 2/28/2022
Current report filing
8-K
Monday, 2/14/2022
Current report filing
8-K
Thursday, 12/23/2021
Current report filing
8-K
Friday, 11/12/2021
Current report filing
8-K
Tuesday, 10/12/2021
Current report filing
8-K
Tuesday, 8/10/2021
Current report filing
8-K
Thursday, 5/13/2021
Current report filing
8-K
Friday, 4/23/2021
Current report filing
8-K
Wednesday, 4/14/2021
Current report filing
8-K
Friday, 2/26/2021
Current report filing
8-K
Tuesday, 2/16/2021
Current report filing
Other (30)
EFFECT
Thursday, 2/1/2024
Notice of Effectiveness
EFFECT
Friday, 12/15/2023
Notice of Effectiveness
CORRESP
Thursday, 12/14/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Monday, 12/4/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
EFFECT
Wednesday, 6/7/2023
Notice of Effectiveness
CORRESP
Monday, 6/5/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
ARS
Friday, 5/26/2023
Annual report to security holders
D
Thursday, 4/27/2023
Exempt (Private) Offering
EFFECT
Wednesday, 3/8/2023
Notice of Effectiveness
CORRESP
Monday, 3/6/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Friday, 2/24/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Thursday, 2/9/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Friday, 1/27/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
EFFECT
Wednesday, 6/8/2022
Notice of Effectiveness
CORRESP
Monday, 6/6/2022
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
EFFECT
Monday, 5/2/2022
Notice of Effectiveness
CORRESP
Thursday, 4/28/2022
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
SEC STAFF LETTER
Wednesday, 2/10/2021
None
CERT
Tuesday, 2/9/2021
Certification by an exchange approving securities for listing
EFFECT
Tuesday, 2/9/2021
Notice of Effectiveness
8-A12B
Monday, 2/8/2021
Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)
CORRESP
Wednesday, 2/3/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Wednesday, 2/3/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Tuesday, 2/2/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Monday, 2/1/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Monday, 2/1/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Thursday, 1/28/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
SEC STAFF LETTER
Tuesday, 11/17/2020
None
CORRESP
Monday, 11/16/2020
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Friday, 10/23/2020
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
Ownership (61)
SC 13G/A
Tuesday, 2/13/2024
Altium Capital Management LP: Major Shareholders
4
Tuesday, 9/26/2023
Kelly Leanne: Statement of changes in beneficial ownership of securities
4
Monday, 8/14/2023
Rongen Roelof: Statement of changes in beneficial ownership of securities
4
Monday, 8/14/2023
SIMPSON CAMILLA V: Statement of changes in beneficial ownership of securities
4
Monday, 8/14/2023
Baker David Charles: Statement of changes in beneficial ownership of securities
4
Monday, 8/14/2023
Szekeres David Leslie: Statement of changes in beneficial ownership of securities
SC 13G
Wednesday, 5/3/2023
Altium Capital Management LP: Major Shareholders
SC 13G
Tuesday, 5/2/2023
TEP Biotech, LLC: Major Shareholders
3
Tuesday, 4/25/2023
Agro Albert: Initial statement of beneficial ownership of securities
SC 13D
Tuesday, 4/25/2023
Chaturvedi Vipin: Major Shareholders
3
Tuesday, 4/25/2023
Hertz Walter Marc: Initial statement of beneficial ownership of securities
SC 13D
Tuesday, 4/25/2023
Hertz Walter Marc: Major Shareholders
3
Tuesday, 4/25/2023
Rongen Roelof: Initial statement of beneficial ownership of securities
3
Tuesday, 4/25/2023
SIMPSON CAMILLA V: Initial statement of beneficial ownership of securities
SC 13D
Tuesday, 4/25/2023
Agro Albert: Major Shareholders
3
Tuesday, 4/25/2023
Chaturvedi Vipin: Initial statement of beneficial ownership of securities
4
Monday, 4/24/2023
Hertz Walter Marc: Statement of changes in beneficial ownership of securities
4
Monday, 4/24/2023
Chaturvedi Vipin: Statement of changes in beneficial ownership of securities
3
Monday, 4/24/2023
Szekeres David Leslie: Initial statement of beneficial ownership of securities
4
Monday, 4/24/2023
Agro Albert: Statement of changes in beneficial ownership of securities
SC 13G/A
Monday, 2/13/2023
Lind Global Fund II LP: Major Shareholders
SC 13G/A
Monday, 1/30/2023
BIGGER CAPITAL FUND L P: Major Shareholders
SC 13G/A
Tuesday, 12/27/2022
Markey John: Major Shareholders
4
Thursday, 12/15/2022
Thorell Marella: Statement of changes in beneficial ownership of securities
SC 13G
Thursday, 9/29/2022
Markey John: Major Shareholders
4
Wednesday, 7/6/2022
Thorell Marella: Statement of changes in beneficial ownership of securities
4
Friday, 6/10/2022
Payne Joseph E: Statement of changes in beneficial ownership of securities
4
Friday, 6/10/2022
Thorell Marella: Statement of changes in beneficial ownership of securities
4
Friday, 6/10/2022
Ammer Richard: Statement of changes in beneficial ownership of securities
SC 13G
Monday, 5/23/2022
Lind Global Fund II LP: Major Shareholders
SC 13G
Monday, 5/23/2022
BIGGER CAPITAL FUND L P: Major Shareholders
SC 13G
Wednesday, 5/18/2022
Lincoln Park Capital Fund, LLC: Major Shareholders
4
Wednesday, 3/9/2022
Chhabra Meenu: Statement of changes in beneficial ownership of securities
3
Wednesday, 3/9/2022
Chhabra Meenu: Initial statement of beneficial ownership of securities
4
Tuesday, 3/1/2022
Kelly Leanne M.: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/1/2022
Baker David Charles: Statement of changes in beneficial ownership of securities
SC 13G
Thursday, 2/17/2022
Malnik Dov: Major Shareholders
SC 13G
Tuesday, 2/15/2022
Arcturus Therapeutics Holdings Inc.: Major Shareholders
4
Friday, 6/4/2021
Kelly Leanne M.: Statement of changes in beneficial ownership of securities
4
Thursday, 5/27/2021
Payne Joseph E: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/18/2021
Kelly Leanne M.: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/18/2021
Baker David Charles: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/18/2021
Toren Penny: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/18/2021
Payne Joseph E: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/18/2021
Ammer Richard: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/18/2021
Levi Ofir: Statement of changes in beneficial ownership of securities
3
Tuesday, 5/18/2021
Kelly Leanne M.: Initial statement of beneficial ownership of securities
SC 13D/A
Tuesday, 3/16/2021
SALMON Pharma GmbH: Major Shareholders
SC 13D
Tuesday, 2/16/2021
SALMON Pharma GmbH: Major Shareholders
4
Friday, 2/12/2021
SALMON Pharma GmbH: Statement of changes in beneficial ownership of securities
4
Friday, 2/12/2021
Ammer Richard: Statement of changes in beneficial ownership of securities
4
Friday, 2/12/2021
Baker David Charles: Statement of changes in beneficial ownership of securities
4
Friday, 2/12/2021
Thorell Marella: Statement of changes in beneficial ownership of securities
3
Wednesday, 2/10/2021
Payne Joseph E: Initial statement of beneficial ownership of securities
3
Wednesday, 2/10/2021
Arcturus Therapeutics Holdings Inc.: Initial statement of beneficial ownership of securities
3
Tuesday, 2/9/2021
Ammer Richard: Initial statement of beneficial ownership of securities
3
Tuesday, 2/9/2021
SALMON Pharma GmbH: Initial statement of beneficial ownership of securities
3
Tuesday, 2/9/2021
Thorell Marella: Initial statement of beneficial ownership of securities
3
Tuesday, 2/9/2021
Toren Penny: Initial statement of beneficial ownership of securities
3
Tuesday, 2/9/2021
Levi Ofir: Initial statement of beneficial ownership of securities
3
Tuesday, 2/9/2021
Baker David Charles: Initial statement of beneficial ownership of securities
Prospectus (40)
424B4
Friday, 2/2/2024
Prospectus filed pursuant to Rule 424(b)(4)
424B3
Friday, 2/2/2024
Prospectus filed pursuant to Rule 424(b)(3)
S-1/A
Wednesday, 1/31/2024
General form of registration statement for all companies including face-amount certificate companies
S-1/A
Wednesday, 1/31/2024
General form of registration statement for all companies including face-amount certificate companies
424B3
Tuesday, 1/30/2024
Prospectus filed pursuant to Rule 424(b)(3)
424B3
Friday, 1/19/2024
Prospectus filed pursuant to Rule 424(b)(3)
424B3
Monday, 1/8/2024
Prospectus filed pursuant to Rule 424(b)(3)
S-1
Thursday, 12/21/2023
General form of registration statement for all companies including face-amount certificate companies
424B3
Friday, 12/15/2023
Prospectus filed pursuant to Rule 424(b)(3)
S-1/A
Monday, 12/4/2023
General form of registration statement for all companies including face-amount certificate companies
S-3
Friday, 10/13/2023
Registration statement for specified transactions by certain issuers
424B3
Wednesday, 6/7/2023
Prospectus filed pursuant to Rule 424(b)(3)
S-3
Tuesday, 5/30/2023
Registration statement for specified transactions by certain issuers
424B3
Friday, 4/21/2023
Prospectus filed pursuant to Rule 424(b)(3)
425
Wednesday, 4/12/2023
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Friday, 4/7/2023
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
424B3
Friday, 4/7/2023
Prospectus filed pursuant to Rule 424(b)(3)
425
Tuesday, 4/4/2023
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
424B3
Friday, 3/31/2023
Prospectus filed pursuant to Rule 424(b)(3)
424B3
Wednesday, 3/8/2023
Prospectus filed pursuant to Rule 424(b)(3)
S-4/A
Monday, 3/6/2023
Registration of securities issued in business combination transactions
S-4/A
Friday, 2/24/2023
Registration of securities issued in business combination transactions
S-4/A
Thursday, 2/9/2023
Registration of securities issued in business combination transactions
S-4/A
Monday, 1/30/2023
Registration of securities issued in business combination transactions
425
Wednesday, 1/11/2023
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
S-4
Friday, 12/23/2022
Registration of securities issued in business combination transactions
424B3
Wednesday, 6/8/2022
Prospectus filed pursuant to Rule 424(b)(3)
S-1
Friday, 5/27/2022
General form of registration statement for all companies including face-amount certificate companies
424B5
Friday, 5/13/2022
Prospectus filed pursuant to Rule 424(b)(5)
424B3
Monday, 5/2/2022
Prospectus filed pursuant to Rule 424(b)(3)
S-3
Tuesday, 4/26/2022
Registration statement for specified transactions by certain issuers
S-8
Monday, 5/10/2021
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B4
Thursday, 2/11/2021
Prospectus filed pursuant to Rule 424(b)(4)
S-1MEF
Tuesday, 2/9/2021
A new registration statement filed under Rule 462(b) to add securities to a prior related effective registration statement filed on Form S-1
S-1/A
Thursday, 1/28/2021
General form of registration statement for all companies including face-amount certificate companies
FWP
Thursday, 1/21/2021
Filing under Securities Act Rules 163/433 of free writing prospectuses
S-1/A
Thursday, 1/14/2021
General form of registration statement for all companies including face-amount certificate companies
S-1/A
Monday, 11/16/2020
General form of registration statement for all companies including face-amount certificate companies
S-1
Friday, 10/23/2020
General form of registration statement for all companies including face-amount certificate companies
DRS
Friday, 9/11/2020
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Proxies (14)
DEFA14A
Monday, 1/8/2024
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEF 14A
Tuesday, 1/2/2024
Definitive proxy statements
PRE 14A
Wednesday, 12/20/2023
Preliminary proxy statement not related to a contested matter or merger/acquisition
DEFA14A
Friday, 5/26/2023
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEF 14A
Friday, 5/26/2023
Definitive proxy statements
DEFA14A
Wednesday, 4/5/2023
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEFA14A
Wednesday, 4/5/2023
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEFA14A
Monday, 4/3/2023
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEFA14A
Thursday, 3/30/2023
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEFA14A
Thursday, 3/23/2023
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEF 14A
Monday, 6/6/2022
Definitive proxy statements
PRE 14A
Wednesday, 5/25/2022
Preliminary proxy statement not related to a contested matter or merger/acquisition
DEFA14A
Wednesday, 4/27/2022
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEF 14A
Wednesday, 4/27/2022
Definitive proxy statements